Education
About Us
Working with TipRanks
Follow Us
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -311.00K | $ -272.00K | $ -326.00K | $ -155.00K |
| Operating Income | $ -90.89M | $ -41.76M | $ -36.53M | $ -50.47M | $ -42.80M |
| EBITDA | $ -90.89M | $ -41.45M | $ -35.08M | $ -50.14M | $ -42.65M |
| Net Income | $ -80.60M | $ -36.95M | $ -34.18M | $ -50.31M | $ -42.33M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 183.45M | $ 86.79M | $ 118.43M | $ 70.10M | $ 92.64M |
| Total Assets | $ 200.22M | $ 95.94M | $ 126.41M | $ 78.67M | $ 104.69M |
| Total Debt | $ 5.12M | $ 5.55M | $ 5.41M | $ 6.00M | $ 6.52M |
| Net Debt | $ -28.10M | $ -21.20M | $ -21.42M | $ -64.09M | $ -61.63M |
| Total Liabilities | $ 28.41M | $ 14.21M | $ 15.50M | $ 14.25M | $ 14.99M |
| Stockholders' Equity | $ 171.81M | $ 81.72M | $ 110.90M | $ 64.41M | $ 89.69M |
| Cash Flow | |||||
| Free Cash Flow | $ -71.28M | $ -33.62M | $ -27.67M | $ -42.44M | $ -42.26M |
| Operating Cash Flow | $ -70.76M | $ -33.46M | $ -27.57M | $ -42.10M | $ -42.20M |
| Investing Cash Flow | $ -85.39M | $ 33.35M | $ -90.96M | $ 24.17M | $ 17.09M |
| Financing Cash Flow | $ 161.88M | $ 30.00K | $ 75.26M | $ 19.89M | $ 93.59M |